Based on multivariate analysis, grade, age, IDH mutation status, chemotherapy status, UNC5A expression, 1p19q codeletion status, and PRS type were all shown to be independent predictors of OS in glioma patients (all p < 0.05; Fig. 5B and Table 1). This evidence concerns the gene UNC5A and central nervous system cancer.